Extended Data Fig. 8: Response of CRC organoid xenografts to nab-paclitaxel or cetuximab treatment.
From: Organoid screening reveals epigenetic vulnerabilities in human colorectal cancer
a, The growth curves of cetuximab- and vehicle-treated xenografts. Each dot and line indicates one mouse. b, Schedule for treating CRC organoid xenografts with cetuximab (top). Sensitivity of CRC organoid xenografts to cetuximab (bottom). Each dot and line indicates one organoid line. c, The relationship between the sensitivity to cetuximab in vitro and in vivo. Each dot shows one organoid line, and the organoids were colored according to the possession of KRAS or BRAF mutation. d, The growth curves of nab-paclitaxel- and vehicle-treated CRC organoid xenografts. Each dot and line indicates one mouse.
